Positive and negative selection of T cell repertoires during differentiation in allogeneic bone marrow chimeras

Positive and negative selection of T cell repertoires during differentiation in allogeneic bone marrow chimeras

Transplant Immunology 12 (2003) 79–88 Positive and negative selection of T cell repertoires during differentiation in allogeneic bone marrow chimeras...

456KB Sizes 3 Downloads 74 Views

Transplant Immunology 12 (2003) 79–88

Positive and negative selection of T cell repertoires during differentiation in allogeneic bone marrow chimeras Kazunori Onoe´ a,*, Toshihiko Gotohdaa, Hiroki Nishihoria, Toshimasa Aranamia, Chikako Iwabuchia, Cristina Iclozana, Taiki Morohashia, Kazumasa Ogasawarab, Robert A. Goodc, Kazuya Iwabuchia a

Institute for Genetic Medicine, Hokkaido University, Sapporo, Japan b Faculty of Medicine, Shiga Medical School, Ohtsu, Japan c Department of Pediatrics, All Children’s Hospital, St. Petersburg, FL, USA Received 23 September 2002; accepted 24 January 2003

Abstract T cells acquire immune functions during expansion and differentiation in the thymus. Mature T cells respond to peptide antigens (Ag) derived from foreign proteins when these peptide Ag are presented on the self major histocompatibility complex (MHC) molecules but not on allo-MHC. This is termed self-MHC restriction. On the other hand, T cells do not induce aggressive responses to self Ag (self-tolerance). Self-MHC restriction and self-tolerance are not genetically determined but acquired a posteriori by positive and negative selection in the thymus in harmony with the functional maturation. Allogeneic bone marrow (BM) chimera systems have been a useful strategy to elucidate mechanisms underlying positive and negative selection. In this communication, the contribution of BM chimera systems to the investigation of the world of T-ology is discussed. 䊚 2003 Elsevier Science B.V. All rights reserved. Keywords: T cell differentiation; Positive selection; Negative selection; Self-MHC restriction; Self-tolerance; MHC class Ib-restricted T cells

1. Introduction Precursor T cells differentiate in the thymus, become immunocompetent, and emigrate to peripheral lymphoid tissues w1,2x. In the process of differentiation thymic lymphocytes undergo positive and negative selection w3–5x. The positive and negative selection of main stream T cells result from interactions between the T cell receptor (TCR) and self peptide presented in the antigen (Ag) binding groove of major histocompatibility complex (MHC) molecules w6–8x. Positive selection Abbreviations: Ab, antibody; Ag, antigen(s); APC, Ag presenting cell(s); BM, bone marrow; BMT, BM transplantation; CFA, complete Freund’s adjuvant; CTL, cytotoxic T lymphocyte; DN, double negative; DP, double positive; GVHR, graft vs. host response; MHC, major histocompatibility complex; MLR, mixed lymphocyte response; PFC, plaque forming cell; p43–58, pigeon cytochrome c peptide 43– 58; SMLR, syngeneic MLR; SRBC, sheep red blood cells; TCR, T cell Ag receptor. *Corresponding author. Division of Immunobiology, Institute for Genetic Medicine, Hokkaido University, Kita-15, Nishi-7, Kita-ku, Sapporo 060-0815, Japan. Tel.: q81-11-706-5531; fax: q81-11-7067545. ´ E-mail address: [email protected] (K. Onoe).

generates a functional T cell repertoire restricted to selfMHC expressed on the epithelial cells of the thymic cortex w9,10x. Negative selection eliminates or anergizes T cells bearing TCR that are aggressively reactive to self-peptide Ag plus MHC. Dendritic cells or macrophages play a major role in negative selection in the thymic medulla w11–15x. Thus, the reactivity of T cells is largely determined by peptides and MHC that are expressed in the thymus, but not by the genetic background of the T cells themselves, including their own MHC. The importance of the MHC expressed on thymic epithelial cells, however, had been obscure until the specificity of the T cells from MHC incompatible chimeric mice were analyzed. The initial findings that T cells acquire MHC restriction a posteriori and are induced to be self-tolerant in the course of differentiation have been made using an irradiation bone marrow (BM) chimera system where hematopoietic cells and radio-resistant cells (e.g. epithelial cells) express different MHC molecules w16–20x. In this communication, the contribution of chimeric mice to the elucidation of the basic mechanisms under-

0966-3274/03/$ - see front matter 䊚 2003 Elsevier Science B.V. All rights reserved. PII: S 0 9 6 6 - 3 2 7 4 Ž 0 3 . 0 0 0 1 2 - 1

80

K. Onoe´ et al. / Transplant Immunology 12 (2003) 79–88

Fig. 1. Time course of reconstitution of the thymus in wB6.Thy 1.1™B6x BM chimeras. Lethally irradiated (10 Gy) B6 hosts were iv transplanted with BM cells depleted of mature T cells. Eight, 16, 21 and 28 days after BMT, surface phenotype of thymocytes was analyzed by flow cytometry. The left panels (a) in each figure show proportions of donor (Thy 1.1) or host (Thy 1.2) cells. The right panels show expressions of CD4 and CD8 on Thy 1.1q or Thy 1.2q thymocytes. Four weeks after BMT almost complete donor chimerism is achieved.

lying functional differentiation and positive and negative selection of T cells is reviewed. 2. Allogeneic BM chimeras Allogeneic BM chimeras in mice are usually prepared by intravenous (i.v.) inoculation of BM cells that have been depleted of mature T cells into lethally irradiated host mice. The time course of reconstitution is influenced by various factors (e.g. the number of BM cells inoculated, mouse strains used as donors and hosts, the irradiation dose, the histocompatibility between donor and host etc.). For instance, we have shown that the population size of the thymic lymphocytes is determined by the host type w21,22x. In addition, a small number of mature T cells in the BM inoculum accelerate the reconstitution of the host immune system by donor hematopoietic cells w23,24x. The donor T cells quickly eliminate radio-resistant host T and NK cells that are involved in the rejection of donor hematopoietic cells (hybrid resistance or genetic resistance) w25,26x. Fig. 1a shows a representative time course of the thymic reconstitution of BM chimeras prepared by a combination of C57BLy6 (B6) (Thy 1.2) host and B6.Thy 1.1 congenic donor wB6.Thy 1.1™B6x. Sixteen days after BM transplantation (BMT) the majority of thymic T cells are of Thy 1.1q donor origin, and at day 28 virtually no host (Thy 1.2q) T cells are present in

the thymus. It should be noted that the remaining host cells are CD4 and CD8 double positive (DP) 16 days after BMT, whereas very few host cells in the thymus at 21 days are CD4 or CD8 single positive (SP). Similar reconstitution patterns are observed in other lymphoid organs such as spleen and lymph nodes, although the complete replacement by donor cells is achieved at slightly later stages than that in the thymus w23,24x. In these peripheral lymphoid tissues, complete replacement occurs first for B cells, a short cell cycle population, and then for T lineage cells and macrophages w24,27x. 3. Functional maturation of T lineage cells in BM chimeras When the phenotype of donor BM-derived thymocytes (Thy l.1q) from wB6.Thy 1.1™B6x chimeric mice is analyzed using CD4 and CD8 markers, most thymocytes are CD4 and CD8 double negative (DN), a very immature population, until 8 days after BMT (Fig. 1b). At 16 days approximately 90% of cells become DP, and small proportions of CD4 or CD8 SP cells are present. During the drastic phenotypic change from DN to DP, these thymocytes vigorously expand in the cortex. Almost normal proportions of CD4 SP and CD8 SP thymocytes are seen later than 21 days after BMT. When fully allogeneic wB6™AKR (H-2k, Thy 1.1)x chimeras

K. Onoe´ et al. / Transplant Immunology 12 (2003) 79–88 Table 1 Responsiveness of T cells from wB6™AKRx chimeras to alloantigens Assay

GVHR CTL MLR SMLRa a b

T cells from wB6™AKRx B6 wB6™AKRx B6 wB6™AKRx B6 wB6™AKRx B6

Target antigens B6 (H-2b) AKR (H-2k) BALByc (H-2d) y y y y y y y q

y qq y qq q qq NDb ND

qq qq qq qq qq qq ND ND

Purified dendritic cells were used as stimulators. Not done.

were analyzed, the reconstitution was slightly delayed compared to wB6.Thy 1.1™B6x chimeras w20,28x. Even within the CD4 or CD8 SP population, cells at different maturation stages are identified using several differentiation markers, i.e. TCR, heat stable Ag, etc. w29x. The responsiveness of chimera thymocytes to stimuli is dependent on the period after BMT and the nature of the stimuli w28x. Nevertheless, in most BM chimera systems, full lymphocyte functions are accomplished 4 or 5 weeks after BMT. Upon stimulation with T cell mitogens or agents such as PMA plus ionomycin, normal proliferative responses are induced in donor T cells of chimeric mice at this stage w20,28x. Thus, it appears that the individual T cells of chimeric mice possess normal immune functions when non-specific stimuli are given. Levels of reactivity comparable to those in normal mice are seen in other immune cells, B cells, NK cells and macrophages, of chimeras 5 weeks after BMT w20,27x. 4. Alloreactivity and tolerance of T cells in BM chimeras When T cells from wB6 (H-2b)™AKR (H-2k)x chimeras are intraperitoneally (ip) injected to neonatal (B6=AKR) F1 mice, no splenomegaly (graft vs. host response, GVHR) is induced (Table 1) w20x. On the other hand, these T cells induce splenomegaly in (B6=BALByc (H-2d)) F1 mice comparable to that induced by T cells of normal B6 mice. Thus, chimera T cells are specifically unresponsive to both donor and host histocompatibility Ag w20,30,31x. Similarly, no cytotoxic T cells (CTL) against donor or host targets are generated from H-2 incompatible chimeras after coculture with stimulator cells from donor or host mice w32x. Thus far, it has been demonstrated that chimera T cells are tolerant of either donor or host Ag, when the reactivity is analyzed by GVHR or CTL assays (Table 1). The tolerance of CTL to either donor or host specific Ag is largely attributed to negative selection during T cell differentiation in the host thymus w20,30x. The elucidation of mechanisms underlying negative selection

81

will be discussed later. It has also been reported that a form of suppressor mechanism might be involved in the unresponsiveness of CTL to donor or host histocompatibility Ag w33–35x. When alloreactivity of T cells from wB6™AKRx chimeras is assessed by mixed lymphocyte reaction (MLR), the T cells mount a considerable proliferative response to host stimulators w36x. The responsiveness is, however, low compared to that in normal B6 mice. On the other hand, T cells from H-2 incompatible chimeras generate no proliferative responses to donor stimulators in syngeneic MLR (SMLR) (Table 1) w37,38x. Recently, we have reported that SMLR represents homeostatic proliferation of various T cell subsets w39x. We would like to postulate that SMLR reflects positive selection in the thymus, which will be discussed in the next chapter. 5. Positive selection and MHC restriction of T cells in BM chimeras To address the immune functions of H-2 incompatible wB6™AKRx chimeras, these mice were ip immunized with sheep red blood cells (SRBC), a T-dependent Ag. Primary antibody (Ab) responses were evaluated using plaque forming cell (PFC) assays after 4 days. These chimeras completely lacked Ab forming cells in the spleen w20x. By contrast, Ab responses to T-independent Ag could be seen in these chimeras w40x. Thus, it appeared that the Ab response to T-dependent Ag was specifically abrogated in wB6™AKRx chimeras. When irradiated AKR host mice were reconstituted with BM cells from B6.H-2k congenic mice, these H-2 compatible wB6.H-2k™AKRx chimeras generated normal levels of Ab response to SRBC w20x. In subsequent studies we found that histocompatibility at H-2A and H-2E loci was sufficient for chimeric mice to mount full primary PFC responses to SRBC (Fig. 2) w40,41x. The lack of a primary Ab response in H-2 incompatible chimeras prompted us to attempt to elucidate the mechanism underlying the immune deficiency. We analyzed in vitro PFC responses to SRBC using T cells from wB6™AKRx chimeras and B cells and antigen presenting cells (APC) from B10 (H-2b) or B10.BR (H-2k) mice w42x. It was clearly shown that helper T cells (Th) of chimeras could generate PFC in combination with B10.BR B cells and APC, but not with B10 cells that express H-2b products identical to those on the Th themselves (Table 2). However, when T cells from H-2 incompatible chimeras and B cells from donor or host H-2 type were adoptively transferred into irradiated (donor=host) F1 mice and then immunized with SRBC, considerable PFC responses were seen with either combination w42x. Thus, in the presence of radioresistant F1 APC, chimera T cells could cooperate with either donor or host H-2 type B cells, suggesting that

82

K. Onoe´ et al. / Transplant Immunology 12 (2003) 79–88

6. Positive selection of particular T cell repertoires under the influence of thymic MHC

Fig. 2. Cooperation between helper T cells and partner cells, B cells and APC, in BM chimeras. Lethally irradiated AKR mice received BMT from B10 (Kb, Ab, E0, Db) or B10.A(2R) (Kk, Ak, Ek, Dk) mice. These wB10™AKRx and wB10.A (2R)™AKRx chimeras were immunized with SRBC and primary anti-SRBC PFC responses were analyzed. In the former wB10™AKRx chimera no PFC response was generated, whereas the wB10.A (2R)™AKRx chimera showed normal level of PFC response. Helper T cells from either chimera recognize Ak and Ek molecules as self, but only helper T cells from wB10.A (2R)™AKRx chimera encounter appropriate partner cells expressing Ak and Ek molecules.

MHC restriction operated between Th and APC but not between Th and B cells w43x. Subsequent analysis with various H-2 recombinant mice again demonstrated that both H-2A and H-2E match between Th and APC was essential for the full Ab response to T-dependent Ag w40,41x. When cell-mediated immune functions were analyzed, similar observations were made. Full anti-Listeria immunity could be achieved in H-2 compatible chimeras but not in chimeras histoincompatible at the H-2 subregions w44x. It was also demonstrated that the histocompatibility of the H-2 subregions determined the responsiveness of CTL to alloantigens in BM chimeric mice w45x. These findings reveal that positive selection by MHC expressed on the radio-resistant epithelial cells of the thymus determines the MHC restriction of the T cells. We would like to emphasize here that importance of the thymic MHC on determining the T cell restriction specificity could not be recognized until T cell functions of MHCincompatible chimera systems were analyzed.

When B6 mice are immunized with pigeon cytochrome c peptide 43–58 (AEGFSYTDANKNKGIT, p43–58) plus complete Freund’s adjuvant (CFA), T cells from regional lymph nodes mount a significant proliferative response to p43–58 in an H-2Ab restricted manner (Fig. 3) w46x. Bm12 mice that carry three amino acid substitutions on H-2Ab generate no T cell response to p43–58, although the H-2Abm12 molecule can bind p43–58 w47x. To examine whether H-2Abm12 molecules cannot positively select the T cell repertoire responding to p43–58, BMT was performed between bm12 donors and B6 hosts. These wbm12™B6x chimeric mice generated no T cell response to p43–58 because of a lack of appropriate APC bearing H-2Ab in vivo (20, 44). We then prepared wB6.Thy 1.1qbm12™B6x mixed chimeras where B6 mice simultaneously received BM cells from B6.Thy 1.1 congenic mice and bm12 mice. Eight weeks later, these chimeric mice were immunized with p43–58 and CFA, and the proliferative responses of Thy l.2q bm12 T cells were evaluated in the presence of B6 or bm12 APC. These bm12 T cells mounted a considerable proliferative response with B6 APC but not with genetically identical bm12 APC (Fig. 3). Thus, p43–58 specific T cells of bm12 origin recognized H-2Ab as self in the mixed chimeras. In addition to determining the role of thymic MHC on T cell restriction, allogeneic chimeras and flow cytometry have been used to examine positive selection of particular T cell subpopulations under the influence of specific MHC class I molecules on thymic epithelial cells. In SWR (H-2q) mice, the expression of Vb17a TCR correlates with only the CD4 SP subpopulation of thymocytes, whereas in thymocytes of SJL (H-2s) mice the expression of Vb17a is detected on both the CD4 and CD8 SP subpopulations. Analysis of allogeneic BM chimeras prepared by reciprocal combinations of SWR and SJL mice demonstrates that the size of the Vb17aq CD8 SP subpopulation is determined by the haplotype of H-2K molecules expressed on thymic Table 2 Anti-SRBC PFC response in vitro or in irradiated F1 mice T cells

B cellsqAPC Assay

Anti-SRBC PFC

wB6™AKRx

B10 B10.BR B10 B10.BR

In vitro

10yculture 248 204 182

B10 B10.BR

In (B6=AKR)F1a 122yspleen 130

(B6=AKR)F1 wB6™AKRx a

Nine Gy-irradiated (B6=AKR)F1 mice were adoptively transferred with T cells from chimeras and non-T cells from B10 or B10.BR mice.

K. Onoe´ et al. / Transplant Immunology 12 (2003) 79–88

83

Amino acid substitutions at the base of the Ag binding groove in B6-H-2bm8 mice led to a significantly altered population size of Vb17aq CD8 SP T cells developing in the thymus of B6-H-2bm8 mice. The role of self peptides in the positive selection was also reported by Bevan’s group w9,49x. 7. Negative selection of self-super Ag reactive T cells in BM chimeras Mls-1a is a super Ag encoded by the open reading frame in the 39-long terminal repeat of endogenous mammary tumor virus, MTV-7 w50x. T cells bearing a Vb6 TCR respond to Mls-1a in the context of H-2E without priming. In AKR (H-2Eq, Mls-1a) mice Vb6q T cells are eliminated by negative selection during differentiation, whereas in B10.BR (H-2Eq, Mls1b) approximately 10% of T cells are Vb6q. To elucidate the mechanism of this negative selection, we prepared wB10.BR™AKRx chimeric mice and the proportion of Vb6q cells was sequentially analyzed w13x. Two weeks after BMT a considerable number of Vb6q cells were seen in the cortex and medulla of the thymus. However, at 3 weeks no Vb6q cells were detected in the medulla, although weakly positive Vb6 cells were still present in the cortex. When various B10 H-2 recombinant mice were used as BM donors, it was shown that clonal elimination was induced in chimeras where H-2Eq strains (B10.AQR) were donors but not in chimeras reconstituted by BMT from H-2Ey donor mice (B10) (Table 3). These findings demonstrate that self-reactive T cells are eliminated in the thymic medulla between 2 and 3 weeks after reconstitution and that H-2Eq donor cells of BM origin, (i.e. macrophages andyor dendritic cells), are responsi-

Fig. 3. T cell proliferative response to p43–58 peptide in B6, bml2 mice and wB6.Thy 1.1qbml2™B6x BM chimeras. Mice were immunized with 20 nmol of p43–58 plus CFA. After 10 days T cell enriched fractions (4=105) from draining lymph nodes were cultured with Ag together with 30 Gy irradiated syngeneic spleen cells (APC: 1=105) in a 96-well flat-bottomed microtiter plate. When BM chimeras were analyzed, T cell enriched fractions were depleted of Thy 1.1q cells before culture and APC were either B6 or bml2 spleen cells. After 3 days of culture 0.5 mCi of w3Hxthymidine was added and the cells were harvested 18 h later. The thymidine incorporation was measured by standard liquid scintillation counting technique.

epithelial cells (Fig. 4) w10x. Subsequent analysis with BM chimeras prepared by SWR donor and various H2K mutant host strains suggested that peptides binding to the groove of the H-2K isoform were involved in the positive selection of Vb17aq CD8 SP T cells w48x.

Fig. 4. Positive selection of Vb17aq CD8q T cells under the influence of various H-2K molecules expressed on epithelial cells in the thymic cortex. BM cells from SWR mice were transplanted into B10 (H-2Kb), B10.A (4R) (H-2Kk, DBAyI (H-2Kq ) or SJL (H-2Ks) mice and the proportion of Vb17aq CD8q T cells was determined in the thymus.

K. Onoe´ et al. / Transplant Immunology 12 (2003) 79–88

84

Table 3 Elimination of Vb6q T cells in various BM chimeras Donor

Host

Vb6 cells (%)

Strain

H-2E

Mls-1

Strain

H-2E

Mls-1

B10 B10.AQR

y q

b b

AKR AKR

q q

a a

10 0

DBAy1 DBAy1

y y

a a

B10 B10.AQR

y q

b b

10 5

ble for the clonal deletion w13,51x. In a subsequent study, we found that thymic epithelial cells were also partially involved in the clonal elimination when a large amount of tolerogens produced by hematopoietic cells (DBAy1) were present (Table 3) w52x. In the presence of minor GVHR, however, clonal elimination of Vb6q cells is abrogated w53x. We demonstrated two different mechanisms underlying the abrogation of negative selection in the GVHR chimeras w54– 56x. These mechanisms have been already reported in a previous review w57x, and we will not further discuss the relationship between GVHR and negative selection in the present review. 8. Negative selection of T cell repertoires specific for p43–58 analog peptides We have determined functional sites, epitope positions and anchor positions, on the p43–58 peptide in mouse strains with various H-2 class II haplotypes w46,58–61x. The 50th and 52nd residues function as epitopes and 46th and 58th residues as anchors to H-2Ab. We then prepared various p43–58 analogs by substituting amino acid residues at these functional sites (Fig. 5). The p43– 58 analog peptides substituted at the 50th epitope posi-

Fig. 5. Amino acid sequence of p43–58 analogs. The peptides are named by substituted positions and amino acids from the original peptide, p43–58, composed of pigeon cytochrome c residues 43–58.

tion, p43–58 (50D), 50E and 50V, stimulate different T cell clones. Residues at the anchor sites determine binding affinity between the peptide and H-2Ab molecule. It has been demonstrated that the binding hierarchy is 50E54A)50E)50E54R or 50V54A)50V)50V54R w58–64x. This hierarchy is directly reflected in the proliferative response of T cells to these analogs. These analogs were then intrathymically (it) injected into wB6™B6x syngeneic BM chimeras at various stages after BMT. At 5 weeks these mice were immunized with the analogs plus CFA; T cell proliferative responses were quantitatively analyzed. When p43–58 analog peptides were it injected into wB6™B6x mice after T cell maturation had been achieved (i.e. 30 days after BMT), no influence of it peptide administration was seen on T cell responsiveness to these peptides. Mice it injected with a high affinity peptide, 50V54A, 3 weeks after BMT, however, mounted low responses to these peptides compared to wB6™B6x mice injected with phosphate buffered saline (PBS) (Fig. 6a and b). The hierarchy of the stimulator peptides, however, was maintained as 50V54A)50V)50V54R. The it administra-

Fig. 6. T cell proliferative response to p43–58 analogs in wB6™B6x BM chimeras. BM chimeras were intrathymically (it) administrated PBS (a) or 50V54A (VA) (b, c) 21 days after BMT. At 5 week post BMT these mice were immunized with VA (a, b) or 50E54A (EA) (c) plus CFA and 10 days later T cell proliferative responses to various analog peptides were determined as in legend of Fig. 3. Note it administration of VA suppresses the response to VA and 50V (b), but not that to EA and 50E (c).

K. Onoe´ et al. / Transplant Immunology 12 (2003) 79–88

85

Fig. 7. T cell proliferative response to p43–58 analogs in wB6™B6x BM chimeras. BM chimeras were intrathymically (it) administrated PBS (a), 50E54A (EA) (b) or 50E54R (ER) (c) 13 days after BMT. At 5 week post BMT these mice were immunized with 50E plus CFA and 10 days later T cell proliferative responses to various analog peptides were determined as in legend of Fig. 2. Note it administration of a high affinity EA results in suppression of the response especially to EA but not to 50E (b), whereas it administration of a low affinity ER exerts no significant influence on the subsequent responses to EA, 50E and ER (c).

tion of 50V54A exerted no significant influence on the responsiveness to the 50E series of peptides that carry glutamic acid at the epitopic 50th site (Fig. 6c). The same result was obtained when the reciprocal combination of the analogs, it administration of 50E54A and immunization with 50V54A, was examined. Thus, it administration of a peptide to chimeric mice at the stage when SP thymocytes are appearing (Fig. 1) seems to lead to epitope-specific negative selection. In the next experiment, a high affinity peptide, 50E54A, was it administrated to wB6™B6x mice 13 days after reconstitution. These mice were subsequently immunized with 50E plus CFA at 5 weeks. In these mice T cell responsiveness was considerably suppressed compared to PBS-treated controls (Fig. 7a and b). In addition, 50E induced a greater response in these T cells than 50E54A in vitro, whereas 50E54A induced a greater response in T cells from mice treated with PBS or 50E54R, a low affinity peptide to H-2Ab, than 50E (Fig. 7c). In our previous study w63x, we reported two T cell clones in 50E54A-immunized B6 mice, one reactive to 50E54A alone and the other reactive to both 50E54A and 50E. Thus, it seems to us that a residue at the 54th site possesses both anchor and epitope functions. This is not truly surprising since dual functions of an amino acid have been reported by both us w60x and other laboratories w65x. It is most likely that it administration of 50E54A eliminates or inhibits the clone reactive to 50E54A alone but not the clone reactive to both 50E54A and 50E. The difference in the negative selection seen between 50E54A-reactive and 50E plus 50E54A-reactive clones may be affected by the affinity of these peptides to H-2Ab. In summary, it administration of a

peptide with high affinity to H-2Ab seems to inhibit T cell clones specific for the peptide in chimeric mice at the stage when clonal elimination of self reactive thymocytes occurs in the thymic medulla. 9. Concluding remarks T cells play a major role in determining the type of immune response generated as well as the regulation of that response. These T cells differentiate and acquire immune functions following two distinct processes, positive and negative selection, mainly in the thymus. In positive selection, MHC molecules expressed on epithelial cells of the thymic cortex interact with the TCR on thymocytes. Conversely during negative selection, MHC molecules on hematopoietic macrophages andyor dendritic cells play an essential role. Several controversial issues, however, still remain concerning the differential functions of these thymic stromal cells w66–69x. Additionally influences of the extrathymic environment on the T cell differentiation should be taken into consideration w70–72x. Indeed, we have reported that repeated or continuous stimulation of T cells with Ag generates T cell responses restricted to the MHC on donor APC in MHC incompatible chimeras w20,42,73,74x. In the past two decades, a number of T cell subsets have been identified, i.e. gdyTCRq cells w75–77x, NKT cells w78–81x, etc. in addition to the mainstream T cells. Some of these subsets undergo differentiation processes quite different from that of mainstream T cells. Indeed, we and others have reported that NK-T cells are positively selected by MHC class Ib on hematopoietic cells under the influence of epithelial cells in the thymic medulla w82–85x. We have also found that

86

K. Onoe´ et al. / Transplant Immunology 12 (2003) 79–88

zeta-associated protein 70 is indispensable to TCR expression on NK-T cells but not that on main stream T cells w86,87x. Differences have been reported by several laboratories in signal pathways and growth factors involved in population expansion and differentiation between mainstream T cells and other T cells subsets w88–95x. As described for mainstream T cells, certain NK-T cells as well as gdyTCRq T cells differentiate extrathymically w88,93,96,97x. More importantly, it has been postulated that these T cell subsets appear to constitute a unique T cell population that is positively selected by non-polymorphic MHC class Ib-like molecules expressed only on hematopoietic cells w98x. Thus, further investigations are needed to completely understand the extraordinarily complex world of T-ology. Acknowledgments This study was supported by Grants-in-Aid for Scientific Research (S, B and C) and a Grant-in-Aid for Special Research Area by the Ministry of Education, Science, Sports and Culture, Japan, Research Grant for Immunology, Allergy and Organ Transplant, by the Ministry of Health and Welfare, Japan. References w1x Good RA. Experiments of nature in the development of modern immunology. Immunol Today 1991;12:283 –286. w2x Scollay R, Wilson A, D’Amico A, et al. Developmental status and reconstitution potential of subpopulations of murine thymocytes. Immunol Rev 1988;104:81 –120. w3x Sprent J, Lo D, Gao EK, Ron Y. T cell selection in the thymus. Immunol Rev 1988;101:171 –190. w4x Teh HS, Kisielow P, Scott B, et al. Thymic major histocompatibility complex antigens and the a b T-cell receptor determine the CD4yCD8 phenotype of T cells. Nature 1988;335:229 –233. w5x Sha WC, Nelson CA, Neeberry RD, Kranz DM, Russel JH, Loh DY. Positive and negative selection of an antigen receptor on T cells in transgenic mice. Nature 1988;336:73 –76. w6x Ashton-Rickardt PG, Banderia A, Delaney JR, et al. Evidence for a differential avidity model of T cell selection in the thymus. Cell 1994;76:651 –663. w7x Marrack P, Kappler J. The T cell receptor. Science 1987;238:1073 –1079. w8x Schwartz RH. T-lymphocyte recognition of antigen in association with gene products of the major histocompatibility complex. Annu Rev Immunol 1985;3:237 –261. w9x Hogquist KA, Gavin MA, Bevan MJ. Positive selection of CD8q T cells induced by major histocompatibility complex binding peptides in fetal thymic organ culture. J Exp Med 1993;177:1469 –1473. w10x Iwabuchi K, Negishi I, Arase H, et al. Positive selection of a T-cell subpopulation in the thymus in which it develops. Proc Natl Acad Sci USA 1989;86:5089 –5093. w11x Kappler JW, Roehm N, Marrack P. T cell tolerance by clonal elimination in the thymus. Cell 1987;49:273 –280. w12x Vasquez NJ, Kaye SJ, Hedrick S. In vivo and in vitro clonal deletion of double-positive thymocytes. J Exp Med 1992;175:1307 –1316.

w13x Fukushi N, Wang B, Arase H, Ogasawara K, Good RA, Onoe´ K. Cell components required for deletion of an autoreactive T cell repertoire. Eur J Immunol 1990;20:1153 –1160. w14x Iwabuchi K, Nakayama K, McCoy RL, et al. Cellular and peptide requirements for in vitro clonal deletion of immature thymocytes. Proc Natl Acad Sci USA 1992;89:9000 –9004. w15x Matzinger P, Zamoyska R, Waldman H. Self-tolerance is H-2restricted. Nature 1984;308:738 –741. w16x von Boehmer H, Sprent J. T cell function in bone marrow chimeras: absence of host-reactive T cell and cooperation of helper T cells across allogeneic barriers. Transplant Rev 1976;29:3 –23. w17x Zinkernagel RM, Callahan GN, Althage A, Cooper S, Klein PA, Klein J. On the thymus in the differentiation of H-2 selfrecognition by T cells: evidence for dual recognition? J Exp Med 1978;147:882 –896. w18x Fink PJ, Bevan MJ. H-2 antigens of the thymus determine lymphocyte specificity. J Exp Med 1978;148:766 –775. w19x Singer A, Hathcock KS, Hodes RJ. Self recognition in allogeneic radiation bone marrow chimeras. A radiation-resistant host element dictates the self specificity and immune response gene phenotype of T-helper cells. J Exp Med 1981;153:1286 –1301. w20x Onoe´ K, Fernandes G, Good RA. Humoral and cell-mediated immune responses in fully allogeneic bone marrow chimera in mice. J Exp Med 1980;151:115 –132. w21x Katsume C, Fernandes G, Iwabuchi K, et al. Strain differences in early development of the thymus-dependent cells: precocity of T lineage cells in AKR mice as compared to those in C3H mice. Microbiol Immunol 1989;33:313 –328. w22x Iwabuchi C, Iwabuchi K, Kobayashi S, et al. Deficiency in early development of the thymus-dependent cells in irradiation chimeras attributable to recipient’s environment. J Immunol 1991;146:26 –34. w23x Arase-Fukushi N, Arase H, Wang B, et al. Influence of a small number of mature T cells in donor bone marrow inocula on reconstitution of lymphoid tissues and negative selection of a T cell repertoire in the recipient. Microbiol Immunol 1993;37:883 –894. w24x Hirano M, Arase H, Arase-Fukushi N, et al. Reconstitution of lymphoid tissues under the influence of subclinical level of graft versus host reaction induced by bone marrow cells or splenic T cell subsets. Cell Immunol 1993;151:118 –132. w25x Cudkowicz G, Bennett M. Peculiar immunology of bone marrow allografts II. Rejection of parental grafts by resistant F1 hybrid mice. J Exp Med 1971;134:1513 –1528. w26x Murphy WJ, Kumar V, Cope JC, Bennett M. An absence of T cells in murine bone marrow allografts leads to an increased susceptibility to rejection by natural killer cells and T cells. J Immunol 1990;144:3305 –3311. w27x Yasumizu R, Onoe´ K, Iwabuchi K, et al. Characteristics of macrophages in irradiation chimera in mice reconstituted with allogeneic bone marrow cells. J Leukoc Biol 1985;38:305 – 315. w28x Ogasawara K, Fukushi N, Arase H, et al. Sequential analysis of the thymocyte differentiation in fully allogeneic bone marrow chimera in mice I. Relationship between functions and surface characteristics of thymocytes. Immunobiology 1990;180:149 –166. w29x Arase H, Fukushi N, Hatakeyama S, et al. Sequential analysis of thymocyte differentiation in fully allogeneic bone marrow chimera in mice II. Further characterization of the CD4q or CD8qsingle-positive thymocytes. Immunobiology 1990;180:167 –183. w30x Onoe´ K, Iwabuchi K, Katsume C, et al. Donor and recipient specific tolerance in cells from semi-allogeneic, H-2 subregion

K. Onoe´ et al. / Transplant Immunology 12 (2003) 79–88

w31x

w32x

w33x w34x

w35x

w36x

w37x

w38x

w39x

w40x

w41x

w42x

w43x

w44x

w45x

w46x

w47x

compatible or fully allogeneic bone marrow chimeras attributable to clonal deletion. Immunobiology 1989;179:172 –189. Onoe´ K, Iwabuchi K, Katsume C, et al. A study on graft versus host reaction (GVHR) by Simonsen’s splenomegaly assay—cells and antigen systems involved in induction of GVHR. Acta Pathol Jpn 1989;38:101 –110. Krown SE, Coico R, Scheid MP, Fernandes G, Good RA. Immune function in fully allogeneic mouse bone marrow chimeras. Clin Immunol Immunopathol 1981;19:268 –275. Miller RG. The veto phenomenon and T-cell regulation. Immunol Today 1986;7:112 –114. Rammensee HG, Fink PJ, Bevan MJ. Functional clonal deletion of class I-specific cytotoxic T lymphocytes by veto cells that express antigens. J Immunol 1984;133:2390 –2396. Ogasawara M, Iwabuchi K, Good RA, Onoe´ K. Bone marrow cells from allogeneic bone marrow chimeras inhibit the generation of cytotoxic lymphocyte responses against both donor and recipient cells. J Immunol 1988;141:3306 –3312. Iwabuchi K, Ogasawara K, Ogasawara M, et al. A study on proliferative responses to host Ia antigens in allogeneic bone marrow chimera in mice. Sequential analysis of the reactivity and characterization of the cells involved in the responses. J Immunol 1987;138:18 –25. Ishida Y, Onoe´ K, Aizawa M. Autologous or syngeneic mixed lymphocyte reaction in bone marrow and thymic chimera mice. Cell Immunol 1982;73:141 –150. Glimcher LH, Schwartz RH, Longo DL, Singer A. The specificity of the syngeneic mixed leukocyte response, a primary anti-I region T cell proliferative response, is determined intrathymically. J Immunol 1982;129:987 –991. Aranami T, Iwabuchi K, Onoe´ K. Syngeneic mixed lymphocyte reaction (SMLR) with dendritic cells: direct visualization of dividing T cell subsets in SMLR. Cell Immunol 2002;217:67 – 77. Onoe´ K, Yasumizu R, Ohishi T, Kakinuma M, Good RA, Morikawa K. Restricted antibody formation to sheep erythrocytes of allogeneic bone marrow chimeras histoincompatible at the K end of the H-2 complex. J Exp Med 1981;153:1009 – 1014. Onoe´ K, Yasumizu R, Geng L, et al. Analyses of Ia restriction specificity of helper T cells in H-2 subregion compatible bone marrow chimera mice. Immunobiology 1985;169:71 –82. Onoe´ K, Yasumizu R, Noguchi M, et al. Analyses of H-2 restriction specificity of helper T cells in fully allogeneic bone marrow chimera in mice. Immunobiology 1985;169:60 –70. Erb P, Meir B, Matsunaga T, Feldman M. Nature of T-cell macrophage interaction in helper-cell induction in vitro II. Two stages of T-helper-cell differentiation analyzed in irradiation and allophenic chimeras. J Exp Med 1979;149:686 –701. Onoe´ K, Good RA, Yamamoto K. Anti-bacterial immunity to Listeria monocytogenes in allogeneic bone marrow chimera in mice. J Immunol 1986;136:4264 –4269. Ogasawara M, Iwabuchi K, Ogasawara K, et al. Generation of cytotoxic T lymphocyte responses to allo-H-2 antigens in allogeneic bone marrow chimeras histocompatible at the H-2 subregions. Immunobiology 1986;172:128 –142. Ogasawara K, Wambua PP, Gotohda T, Onoe´ K. Modification of the T cell responsiveness to synthetic peptides by substituting amino acids on agretopes. Int Immunol 1990;2:219 –224. Onoe´ K, Gotohda T, Itoh Y, Ogasawara K. Generation of the T cell repertoire crossreactive to a self peptide antigen influenced by the MHC class II mutation. In: Yoshida TO, Wilson JM, editors. Molecular approaches to the study and treatment of human diseases. Tokyo: Elsevier Science Publishers, 1992. p. 111 –121.

87

w48x Negishi I, Ogasawara K, Iwabuchi K, Wang B, Good RA, Onoe´ K. H-2K molecules positively select Vb17aq CD4y 8qT cells in bone marrow and thymic chimeras. Cell Immunol 1991;136:185 –193. w49x Nikolic-Zugic ¨ J, Bevan MJ. Role of self-peptides in positively selecting T-cell repertoire. Nature 1990;344:65 –67. w50x Abe R, Hodes RJ. T-cell recognition of minor lymphocyte stimulating (Mls) gene products. Annu Rev Immunol 1991;7:683 –708. w51x Speiser DE, Chvatchko Y, Zinkernagel RM, MacDonald HR. Distinct fate of self-specific T cells developing in irradiation bone marrow chimeras: clonal deletion, clonal energy, or in vitro responsiveness to self-Mls-1a controlled by hemopoietic cells in the thymuses. J Exp Med 1990;172:1305 –1314. w52x Arase H, Arase N, Ogasawara K, Good RA, Onoe´ K. Clonal elimination of self reactive Vb6q T cells induced by H-2 products expressed on thymic radio-resistant components. Int Immunol 1992;4:75 –82. w53x Fukushi N, Arase H, Wang B, et al. Thymus: a direct target tissue in graft versus host reaction after allogeneic bone marrow transplantation which results in abrogation of induction of selftolerance. Proc Natl Acad Sci USA 1990;87:6301 –6305. w54x Arase-Fukushi N, Arase H, Ogasawara K, Good RA, Onoe´ K. Production of minor lymphocyte stimulatory-1a antigen from activated CD4q or CD8q T cells. J Immunol 1993;151:4445 – 4454. w55x Morohashi T, Ogasawara K, Kitaichi N, Iwabuchi K, Onoe´ K. Significant MLR but not CTL responses against recipient antigens generated in T cells from bone marrow chimeras recovered from GVHD. Bone Marrow Transplant 2000;26:1069 –1076. w56x Morohashi T, Ogasawara K, Kitaichi N, Iwabuchi K, Onoe´ K. Abrogation of negative selection by GVHR induced by minor histocompatibility antigens or H-2D antigen alone. Immunobiology 2000;202:268 –279. w57x Onoe´ K, Arase N, Arase H, et al. Influence of graft versus host reaction on the T cell repertoire differentiating from bone marrow precursor following allogeneic bone marrow transplantation. Transplant Immunol 1997;5:75 –82. w58x Itoh Y, Ogasawara K, Takami K, et al. Determination of amino acids on agretopes of pigeon cytochrome c related peptides specifically bound to I-A allelic products. Eur J Immunol 1994;24:76 –83. w59x Gotohda T, Ogasawara K, Wambua PP, Onoe´ K. Analysis of functional sites on a peptide antigen, p43–58, in I-A or I-Erestricted T cell responses. Int Immunol 1991;3:503 –509. w60x Itoh Y, Kajino K, Ogasawara K, et al. Determination of the allele specific antigen-binding site on I-Ak and I-Ab molecules. Eur J Immunol 1996;26:1314 –1321. w61x Itoh Y, Kajino K, Ogasawara K, et al. Interaction of pigeon cytochrome c (43–58) analogs with either T cell antigen receptor or I-Ab molecule. Proc Natl Acad Sci USA 1997;94:12047 –12052. w62x Ogasawara K, Naruse H, Itoh Y, et al. A strategy for making synthetic peptide vaccines. Proc Natl Acad Sci USA 1992;89:8995 –8999. w63x Itoh Y, Ogasawara K, Gotohda T, Takami K, Naruse H, Onoe´ K. A hole in the T cell repertoire specific for a pigeon cytochrome c related peptide associated with amino acid substitutions on I-Ab molecules. Int Immunol 1992;2:779 –787. w64x Ogasawara K, Onoe´ K. MHC binding motifs and design of peptide-based vaccines. Trends Microbiol 1993;1:276 –279. w65x Brown JH, Jardetzky TS, Gorga JC, et al. Three dimensional structure of the human class II histocompatibility antigen HLADR1. Nature 1993;364:33 –39.

88

K. Onoe´ et al. / Transplant Immunology 12 (2003) 79–88

w66x Longo DL, Kruisbeek AM, Davis ML, Matis LA. Bone marrow-derived thymic antigen-presenting cells determine selfrecognition of Ia-restricted T lymphocytes. Proc Natl Acad Sci USA 1985;82:5900 –5904. w67x Ron Y, Lo D, Sprent J. T cell specificity in twice-irradiated F1-parent bone marrow chimeras. Failure to detect a role for immigrant marrow-derived cells in imprinting intrathymic H-2 restriction. J Immunol 1986;137:1764 –1771. w68x Sharrow SO, Mathieson BJ, Singer A. Cell surface appearance of unexpected host MHC determinants on thymocytes from radiation bone marrow chimeras. J Immunol 1981;126:1327 – 1335. w69x Kaneda R, Iwabuchi K, Kasai M, Murakami M, Uede T, Onoe´ K. Selective antigen presenting activity of cortical thymic epithelial cells against CD4qT cells associated with both lack of costimulatory molecules and inefficient presentation of MHC-peptide ligands. Cell Immunol 1997;181:163 –171. w70x Stockinger H, Bartlett R, Pfizenmaier K, Rollinghoff ¨ M, Wagner H. H-2 restriction as a consequence of intentional priming. Frequency analysis of alloantigen restricted trinitrophenyl-specific cytotoxic T lymphocyte precursors within thymocytes of normal mice. J Exp Med 1981;153:1629 –1639. w71x Nickoloff BJ, Turka LA. Immunological functions of nonprofessional antigen-presenting cells: new insights from studies of T-cell interactions with kerationocytes. Immunol Today 1994;15:464 –469. w72x Poussier P, Teh HS, Julius M. Thymus-independent positive and negative selection of T cells expressing a major histocompatiblity complex class I restricted transgenic T cell receptor ayb in the intestinal epithelium. J Exp Med 1993;178:1947 – 1957. w73x Noguchi M, Onoe´ K, Ogasawara M, et al. H-2 incompatible bone marrow chimeras produce donor-H-2-restricted Ly-2 suppressor T-cell factor(s). Proc Natl Acad Sci USA 1985;82:7063 –7067. w74x Noguchi M, Ogasawara M, Iwabuchi K, et al. Recipient microenvironment does not dictate Igh-V restriction specificity of T cell suppressor inducer factor (TsiF) from allogeneic bone marrow chimera in mice. J Immunol 1985;135:2557 –2561. w75x Pardoll DN, Fowlkes BJ, Lew AM, et al. Thymus-dependent and thymus-independent developmental pathways for peripheral T cell receptor-g d-bearing lymphocytes. J Immunol 1988;140:4091 –4096. w76x Wu J, Groh V, Spies T. T cell antigen receptor engagement and specificity in the recognition of stress-inducible MHC class I-related chains by human epithelial g d T cells. J Immunol 2002;169:1236 –1240. w77x Carding SR, Egan PJ. g d T cells: functional plasticity and heterogeneity. Nat Rev Immunol 2002;2:336 –345. w78x Arase H, Arase N, Ogasawara K, Good RA, Onoe´ K. An NK1.1q CD4q8y single positive thymocyte subpopulation that expresses a highly skewed T-cell antigen receptor V b family. Proc Natl Acad Sci USA 1992;89:6506 –6510. w79x Arase H, Arase N, Kobayashi Y, Nishimura Y, Yonehara S, Onoe´ K. Cytotoxicity of fresh NK1.1q T-cell receptor a bq thymocytes against a CD4q8q thymocyte population associated with intact Fas antigen expression on the target. J Exp Med 1994;180:423 –432. w80x Bendelac A. Mouse NK1.1q T cells. Cur Opin Immunol 1995;7:367 –374.

w81x MacDonald HR. NK1.1q T cell: receptor-ayb cells: new clues to their origin, specificity, and function. J Exp Med 1995;182:633 –638. w82x Bendelac A. Positive selection of mouse NK1q T cells by CD1-expressing cortical thymocytes. J Exp Med 1995;182:2091 –2096. w83x Coles MC, Raulet DH. Class I dependence of the development of CD4q CD8y NKl.1q thymocytes. J Exp Med 1994;180:395 –399. w84x Nakagawa K, Iwabuchi K, Ogasawara K, et al. Generation of NK1.1q TCR aybq thymocytes associated with intact thymic structure. Proc Natl Acad Sci USA 1997;94:2472 –2477. w85x Konishi J, Iwabuchi K, Iwabuchi C, et al. Thymic epithelial cells responsible for impaired generation of NK-T thymocytes in alymphoplasia mutant mice. Cell Immunol 2000;206:26 – 35. w86x Tone S, Iwabuchi K, Iwabuchi C, Negishi I, Onoe´ K. Induction of NK1.1q a b TCRq T cells by bypassing TCR signal in ZAP-70 deficient mice. Immunol Lett 2000;73:65 –69. w87x Iwabuchi K, Iwabuchi C, Tone S, et al. Defective development of NK1.1q T cell antigen receptor a bq cells in zeta-associated protein 70 null mice with an accumulation of NK1.1q CD3y NK-like cells in the thymus. Blood 2001;97:1765 –1775. w88x Ohteki T, Ho S, Suzuki H, Mak TW, Ohashi PS. Role for IL15yIL-15 receptor b-chain in natural killer 1.1q T cell receptora bq cell development. J Immunol 1997;159:5931 –5935. w89x Sato H, Nakayama T, Tanaka Y, et al. Induction of differentiation of pre-NK-T cells to mature V a 14 NKT cells by granulocyteymacrophage colony-stimulating factor. Proc Natl Acad Sci USA 1999;96:7439 –7444. w90x Di Santo JP, Rodewald HR. In vivo roles of receptor tyrosine kinases and cytokine receptors in early thymocyte development. Curr Opin Immunol 1988;10:196 –207. w91x Arase H, Ono S, Arase N, et al. Developmental arrest of NK1.1q T cell antigen receptor a bq T cells and expansion of NK1.1q TCR gydq T cell development in CD3z-deficient mice. J Exp Med 1995;182:891 –895. w92x Alberola-Ila J, Hogquist KA, Swan KA, Bevan MJ, Perlmutter RM. Positive and negative selection invoke distinct signaling pathways. J Exp Med 1996;184:9 –18. w93x Ohteki T, Wilson A, Verbeek S, MacDonald HR, Clevers H. Selectively impaired development of intestinal T cell receptor gydq cells and liver CD4q NK1.1q T cell receptor a bq cells in T cell factor-1-deficient mice. Eur J Immunol 1996;26:351 –355. w94x Gadue P, Morton N, Stein PL. The Src family tyrosine kinase Fyn regulates natural killer T cell development. J Exp Med 1999;190:1189 –1196. w95x Eberl G, Fehling HJ, von Boehmer H, MacDonald HR. Absolute requirement for the pre-T cell receptor a chain during NK1.1q TCR a b cell development. Eur J Immunol 1999;29:1966 –1971. w96x Hashimoto W, Takeda K, Anzai R, et al. Cytotoxic NK1.1 Agq a b T cells with intermediate TCR induced in the liver of mice by IL-12. J Immunol 1995;154:4333 –4340. w97x Takeda K, Seki S, Ogasawara K, et al. Liver NK1.1 CD4q a b T cells activated by IL-12 as a major effector in inhibition of experimental tumor metastasis. J Immunol 1996;156:3366 – 3373. w98x Urdahl KB, Sun JC, Bevan MJ. Positive selection of MHC class Ib-restricted CD8q T cells on hematopoietic cells. Nat Immunol 2002;3:772 –778.